NMC, ProPAC discuss alternative methods for EPO reimbursement.
Neumann
M E
ME
D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000191:economics*; D014481:United States
D004921:Erythropoietin